hyprtension - diagnosis and management

Information about hyprtension - diagnosis and management

Published on July 31, 2014

Author: toufiqurrahman52

Source: authorstream.com

Content

Hypertension –Diagnosis and Management: Hypertension –Diagnosis and Management Dr. Md.Toufiqur Rahman MBBS, FCPS , MD, FACC , FESC, FRCPE , FSCAI, FAPSC, FAPSIC , FAHA, FCCP, FRCPG Associate Professor of Cardiology National Institute of Cardiovascular Diseases, Sher -e- Bangla Nagar, Dhaka-1207 Consultant, Medinova , Malibagh branch Honorary Consultant, Apollo Hospitals, Dhaka and STS Life Care Centre, Dhanmondi [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] PowerPoint Presentation: [email protected] summary: summary There are distinct advantages and disadvantages of measuring BP at home  versus the clinic or office. White­coat  hypertension is not benign, and should probably be treated with  aggressive lifestyle modification, and possibly with pharmacologic therapy. In all patients, a careful history and physical examination should be directed to  the following objectives:  1)  toidentify  secondary causes of hypertension,  2) to establish the presence and severity of hypertensive  target­organ damage, and  3) to develop a comprehensive CV risk profile. Laboratory evaluation should be tailored to the same objectives, and should  include serum sodium,  potassium,BUN ,  creatinine ,  eGFR , fasting glucose and lipid profile, urinalysis, and measurement of the  albumin:creatinine ratio in a spot urine sample. [email protected] summary: summary The threshold for pharmacologic treatment is 140/90 mm Hg, except in patients with diabetes, CKD, CAD,  CADequivalents  ( cerebrovascular  disease, carotid  artery disease, aortic aneurysm, peripheral vascular disease) and those with a Framingham risk score of =10%, in whom the threshold is 130/80 mm Hg. There is clear evidence from clinical trials that changes in lifestyle, including  weight loss and maintenance  ofnormal  body weight; increased physical  activity; dietary modification to include more fruits, vegetables, and low  fatdairy  products; moderation of alcohol intake; and sodium reduction in  salt­ sensitive individuals, can lower BP  inboth  hypertensive and  prehypertensive  persons, and can prevent hypertension in the latter group. Maintenance or adoption of a healthy lifestyle is recommended for all persons  irrespective of BP, and is an important adjunct to pharmacologic therapy in patients with hypertension. [email protected] PowerPoint Presentation: Thank you ! [email protected]

Related presentations


Other presentations created by toufiqurrahman52

echo reporting basics
22. 07. 2014
0 views

echo reporting basics

cardio cerebral resuscitation
02. 08. 2014
0 views

cardio cerebral resuscitation

Cardiovascular system assessment
01. 08. 2014
0 views

Cardiovascular system assessment

Management of Hypertension
11. 08. 2014
0 views

Management of Hypertension

echo evaluation 4
18. 08. 2014
0 views

echo evaluation 4

Echocardiography evaluation  3
18. 08. 2014
0 views

Echocardiography evaluation 3